Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NuDYN dose comparison in knee osteoarthritis
NCT04201743Phase 4Withdrawn
- Sponsor
- Illinois Center for Orthopaedic Research and Education
- Start
- Mar 2020
- Primary completion
- Jun 2021
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of NuDYN in osteoarthritis (OA) (2 arms), sponsored by Illinois Center for Orthopaedic Research and Education. Primary endpoints: Knee Injury and Osteoarthritis Outcome Score at 180 days, Visual Analog Scale at 180 days and 1 more. Planned start Mar 2020; status: withdrawn.
02
Drugs
NuDYN
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04201743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04201743.